Literature DB >> 10359807

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB.

V Groh1, R Rhinehart, H Secrist, S Bauer, K H Grabstein, T Spies.   

Abstract

Human MHC class I-related molecules, MICA and MICB, are stress-induced antigens that are recognized by a subset of gamma delta T cells expressing the variable region Vdelta1. This functional association has been found to be limited to intestinal epithelium, where these T cells are prevalent and where MICA and, presumably, MICB are mainly expressed. However, increased frequencies of Vdelta1 gamma delta T cells have been observed in various epithelial tumors; moreover, MICA/B are expressed on diverse cultured epithelial tumor cells. With freshly isolated tumor specimens, expression of MICA/B was documented in many, but not all, carcinomas of the lung, breast, kidney, ovary, prostate, and colon. In tumors that were positive for MICA/B, the frequencies of Vdelta1 gamma delta T cells were significantly higher than in those that were negative. Vdelta1 gamma delta T cell lines and clones derived from different tumors recognized MICA/B on autologous and heterologous tumor cells. In accord with previous evidence, no constraints were observed in these interactions, such as those imposed by specific peptide ligands. Thus, MICA/B are tumor-associated antigens that can be recognized, in an apparently unconditional manner, by a subset of tumor-infiltrating gamma delta T cells. These results raise the possibility that an induced expression of MICA/B, by conditions that may be related to tumor homeostasis and growth, could play a role in immune responses against tumors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10359807      PMCID: PMC22010          DOI: 10.1073/pnas.96.12.6879

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

Review 1.  Biology of the human gamma delta T-cell receptor.

Authors:  S Porcelli; M B Brenner; H Band
Journal:  Immunol Rev       Date:  1991-04       Impact factor: 12.988

Review 2.  The immunobiology of gamma delta+ T cells.

Authors:  J P Allison; D H Raulet
Journal:  Semin Immunol       Date:  1990-01       Impact factor: 11.130

Review 3.  Peptides naturally presented by MHC class I molecules.

Authors:  H G Rammensee; K Falk; O Rötzschke
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

4.  Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens.

Authors:  P Parham; C J Barnstable; W F Bodmer
Journal:  J Immunol       Date:  1979-07       Impact factor: 5.422

5.  Allelic repertoire of the human MHC class I MICA gene.

Authors:  N Fodil; L Laloux; V Wanner; P Pellet; G Hauptmann; N Mizuki; H Inoko; T Spies; I Theodorou; S Bahram
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

6.  Selective lysis of the autologous tumor by delta TCS1+ gamma/delta+ tumor-infiltrating lymphocytes from human lung carcinomas.

Authors:  M R Zocchi; M Ferrarini; C Rugarli
Journal:  Eur J Immunol       Date:  1990-12       Impact factor: 5.532

7.  MHC-unrestricted cytotoxic and proliferative responses of two distinct human gamma/delta T cell subsets to Daudi cells.

Authors:  P Fisch; K Oettel; N Fudim; J E Surfus; M Malkovsky; P M Sondel
Journal:  J Immunol       Date:  1992-04-15       Impact factor: 5.422

8.  A major fraction of human intraepithelial lymphocytes simultaneously expresses the gamma/delta T cell receptor, the CD8 accessory molecule and preferentially uses the V delta 1 gene segment.

Authors:  K Deusch; F Lüling; K Reich; M Classen; H Wagner; K Pfeffer
Journal:  Eur J Immunol       Date:  1991-04       Impact factor: 5.532

9.  Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin.

Authors:  M J Maeurer; D Martin; W Walter; K Liu; L Zitvogel; K Halusczcak; H Rabinowich; R Duquesnoy; W Storkus; M T Lotze
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

10.  Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire.

Authors:  C M Parker; V Groh; H Band; S A Porcelli; C Morita; M Fabbi; D Glass; J L Strominger; M B Brenner
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

View more
  302 in total

Review 1.  A role for epithelial gammadelta T cells in tissue repair.

Authors:  W L Havran
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

2.  Innate immunity to carcinomas?

Authors:  S J Golby; J Spencer
Journal:  Gut       Date:  2000-06       Impact factor: 23.059

Review 3.  A role for epithelial gamma delta T cells in tissue repair.

Authors:  D A Witherden; S E Rieder; R Boismenu; W L Havran
Journal:  Springer Semin Immunopathol       Date:  2000

Review 4.  gamma delta T cells in autoimmunity.

Authors:  Z Yin; J Craft
Journal:  Springer Semin Immunopathol       Date:  2000

Review 5.  Tissue distribution, antigen specificity and effector functions of gamma delta T cells in human diseases.

Authors:  G De Libero
Journal:  Springer Semin Immunopathol       Date:  2000

Review 6.  Antigen recognition by human gamma delta T cells: pattern recognition by the adaptive immune system.

Authors:  C T Morita; R A Mariuzza; M B Brenner
Journal:  Springer Semin Immunopathol       Date:  2000

Review 7.  The major histocompatibility complex-encoded HFE in iron homeostasis and immune function.

Authors:  L Salter-Cid; P A Peterson; Y Yang
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 8.  Induction of T cell alertness by bacterial colonization of intestinal epithelium.

Authors:  Thomas Spies
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

9.  Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA.

Authors:  Vannary Tieng; Chantal Le Bouguénec; Laurence du Merle; Philippe Bertheau; Pierre Desreumaux; Anne Janin; Dominique Charron; Antoine Toubert
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

10.  NKG2D initiates caspase-mediated CD3zeta degradation and lymphocyte receptor impairments associated with human cancer and autoimmune disease.

Authors:  Nobuyoshi Hanaoka; Bana Jabri; Zhenpeng Dai; Cezary Ciszewski; Anne M Stevens; Cassian Yee; Hideki Nakakuma; Thomas Spies; Veronika Groh
Journal:  J Immunol       Date:  2010-10-06       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.